1. Home
  2. SLDB vs ASIX Comparison

SLDB vs ASIX Comparison

Compare SLDB & ASIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$8.33

Market Cap

498.6M

Sector

Health Care

ML Signal

HOLD

Logo AdvanSix Inc.

ASIX

AdvanSix Inc.

HOLD

Current Price

$23.04

Market Cap

527.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDB
ASIX
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
498.6M
527.0M
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
SLDB
ASIX
Price
$8.33
$23.04
Analyst Decision
Strong Buy
Buy
Analyst Count
11
2
Target Price
$16.36
$26.00
AVG Volume (30 Days)
1.0M
450.0K
Earning Date
05-14-2026
05-01-2026
Dividend Yield
N/A
2.75%
EPS Growth
34.97
11.11
EPS
N/A
1.80
Revenue
$8,094,000.00
$1,684,625,000.00
Revenue This Year
N/A
$4.19
Revenue Next Year
N/A
$4.60
P/E Ratio
N/A
$12.97
Revenue Growth
N/A
45.49
52 Week Low
$2.45
$14.10
52 Week High
$8.87
$25.94

Technical Indicators

Market Signals
Indicator
SLDB
ASIX
Relative Strength Index (RSI) 59.74 52.81
Support Level $5.16 $20.28
Resistance Level $8.47 $25.74
Average True Range (ATR) 0.62 0.93
MACD 0.06 -0.30
Stochastic Oscillator 72.18 5.79

Price Performance

Historical Comparison
SLDB
ASIX

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About ASIX AdvanSix Inc.

AdvanSix Inc is a diversified chemistry company playing a critical role in international supply chains, innovating and delivering essential products for customers across a wide variety of end markets and applications that touch people's lives, including building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, and electronics. The company's key products include Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates. The majority of sales are from Plant Nutrients products. The company operates in the United States and internationally, with the majority of revenue coming from the United States.

Share on Social Networks: